Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma

Asthma Clinical Trial

Official title:

Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03036982
• Other study ID #: FP01013808
• Status: Completed
• First received: July 27, 2015
• Last updated: March 26, 2018
• Start date: January 1, 2016
• Est. completion date: December 31, 2017

Study information

• Verified date: March 2018
• Source: Boston Children’s Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study will assess whether adaption of the Asthma Control Test (ACT) and childhood Asthma Control Test (cACT) for mobile devices improves rate of completion and improves control of asthma in children and adolescents

Description:

Asthma is the most prevalent chronic disease of childhood with an overall prevalence of 10%. While effective therapies exist to control symptoms and prevent exacerbations, many asthma patients experience significant morbidity including limitations on daily activities as well as asthma exacerbations that lead to missed school (and work for care givers) and necessitate emergency department visits and hospitalizations. Among children from lower socioeconomic statues and in black and Hispanic families, asthma incidence and severity are even greater. Reasons for this disparity included decreased access to effective asthma care, increased exposure to tobacco smoke and environmental allergens, and underutilization of controller medicines. These groups have significantly increased resource utilization due to emergency department visits and hospitalizations. Optimal care for asthma patients, especially those with at highest risk, will therefore require new strategies for evaluating ongoing control and providing direct feedback to patients.

We propose to transform the way asthma care is provided through the use of an innovative patient centered technology -Trivox Asthma ‐ to improve quality of care and outcomes for asthma patients while reducing the cost of care. Specifically we will extend Trivox Health to facilitate closer monitoring of patients with asthma through the existing web platform and a new mobile interface. This will allow asthma patients, their parents and school nurses to remotely input data on asthma control through smartphones and/or tablets. We will use the ACT+, an expansion of a validated measure currently utilized in both primary care and specialty clinics, to measure both asthma control and risk.

Effectiveness of this intervention will be measured by examining resource utilization and ongoing asthma control.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 221
• Est. completion date: December 31, 2017
• Est. primary completion date: April 30, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 4 Years to 21 Years

Eligibility

Inclusion Criteria:

• Diagnosis of asthma

• Cared for at Boston Children's Hospital (Primary or secondary care)

Exclusion Criteria:

• Age <4 or >21

Related Conditions & MeSH terms

• Asthma

Locations

Country	Name	City	State
United States	Boston Childrens Hospital	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Boston Children’s Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Well-controlled asthma	Percent of ACT scores with value of 20 or greater	Each month for one calendar year
Secondary	Asthma Emergency Department visits and hospitalizations	Asked every 3 months	Total Emergency Department Visits and hospitalizations with asthma as one of top diagnosis in one year